Molecular Insight finalizes Onalta manufacturing and supply agreements
Molecular Insight Pharmaceuticals announced that it has executed an exclusive 10-year agreement to supply the Onalta 90-Y edotreotide radiotherapeutic to BioMedica Life Sciences S.A., Athens, Greece. :theflyonthewall.com
News For MIPI From The Last 14 Days
Check below for free stories on MIPI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
